Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Daiichi Sankyo
US Department of Justice
Argus Health
Boehringer Ingelheim

Generated: December 11, 2017

DrugPatentWatch Database Preview

Details for Patent: 5,498,598

« Back to Dashboard

Summary for Patent: 5,498,598

Title: Composition for nasal administration of desmopressin
Abstract:An aqueous composition for spray nasal administration of a synthetic analog of vasopressin (desmopressin; actate containing between 2.5 and 7.5 .mu.g per 100 .mu.l. The composition may additionally contain an osmotic-pressure controlling agent, such as sodium chloride, a preservative, such as chlorobutanol or benzalkonium chloride, and a buffer stabilizing the pH between about 4 and 6. Buffers containing citrate and/or phosphate are preferred. Also disclosed is a sealed container filled with the composition, an assembly comprising the container and a spray pump, and the use of the composition, the container, and the assembly in the management of urinary disorders.
Inventor(s): Harris; Alan (Malmo, SE)
Assignee: Ferring AB (Malmo, SE)
Application Number:08/430,131
Patent Claim Types:
see list of patent claims

No matches for this query

International Patent Family for Patent: 5,498,598

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria203412► Subscribe
Canada2166312► Subscribe
China1101701► Subscribe
China1126439► Subscribe
Czech Republic282456► Subscribe
Czech Republic9503390► Subscribe
Germany69427820► Subscribe
Denmark0708657► Subscribe
European Patent Office0708657► Subscribe
Spain2158898► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
Queensland Health
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch: